Browse > Article
http://dx.doi.org/10.18325/jkmr.2022.32.3.131

Hepatic and Renal Safety of Concurrent Use of Conventional and Herbal Medications for Musculoskeletal Disorders: A Retrospective Observational Study  

Kim, Se-Yoon (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Kim, Hyungsuk (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Kang, Doyoung (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Ko, Junhyuk (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Kim, Jongyeon (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Kim, Koh-Woon (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Kim, Bo-Hyung (East-West Medical Research Institute, Kyung Hee University)
Cho, Jae-Heung (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Song, Mi-Yeon (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Chung, Won-Seok (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Publication Information
Journal of Korean Medicine Rehabilitation / v.32, no.3, 2022 , pp. 131-140 More about this Journal
Abstract
Objectives This study aimed to investigate whether the concurrent use of conventional and herbal medications affects liver and kidney function, by examining blood test data. Methods We retrospectively reviewed the electronic medical records of 590 inpatients with musculoskeletal diseases between 2013 and 2017. We investigated cases of drug-induced liver injury (DILI) according to the Roussel Uclaf Causality Assessment Method criteria and cases of drug-induced kidney injury (DIKI) based on the Kidney Disease Improving Global Outcomes definition. Results One case (0.17%) of DILI and one case (0.17%) of DIKI were identified. Significant improvements in serum laboratory data were observed after the concurrent use of both types of medications (p<0.05). The kappa coefficients ranged from 0.26 to 0.72, indicating that the values after the concurrent use of conventional and herbal medications showed a fair similarity to the baseline values of the patients. The linear regression test showed that female sex and high body mass index (BMI) were risk factors for an increase in the serum blood levels of liver function parameters. Conclusions The concurrent use of conventional and herbal medications for musculoskeletal disorders is relatively safe; however, clinicians should exercise caution when prescribing these medications to female patients and patients with a high BMI because of their potential effect on hepatic function.
Keywords
Drug-induced kidney injury; Chemical and drug induced liver injury; Herbal medication; Musculoskeletal disorder; Retrospective studies;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Katarey D, Verma S. Drug-induced liver injury. Clin Med (Lond). 2016;16(Suppl 6):s104-9.   DOI
2 Posadzki P, Watson LK, Alotaibi A, Ernst E. Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: Systematic review of surveys. Clin Med (Lond). 2013;13:126-31.
3 Lee J, Shin JS, Kim MR, Byun JH, Lee SY, Shin Y, Kim H, Park KB, Shin BC, Lee MS, Ha IH. Liver enzyme abnormalities in taking traditional herbal medicine in Korea: A retrospective large sample cohort study of musculoskeletal disorder patients. J Ethnopharmacol. 2015;169:407-12.   DOI
4 Lee Y. The clinical report about patients with Alcoholic liver disease given Gamichunggan-san. J Int Korean Med. 2001;22:414-9.
5 Meier Y, Cavallaro M, Roos M, Pauli-Magnus C, Folkers G, Meier P, Fattinger K. Incidence of drug-induced liver injury in medical inpatients. Eur J Clin Pharmacol. 2005;61:135-43.   DOI
6 Kim TS, Kim CY, Min JY, Choi YG, Kang DH. The effects of use of Sasang-bang with Western medicine on liver and kidney function. J Sasang Constit Med. 2004;16:70-5.
7 Lee SW, Park SW, Lee HC, Ko CN, Yun SW, Han JY. The effects of constant use of herbal medicine with western medicine on liver and kidney functions. J Int Korean Med. 2003;24:68-74.
8 Kwon H, Lee S, Kim SE, Lee JH, Jee YK, Kang HR, Park BJ, Park JW, Hong CS. Spontaneously reported hepatic adverse drug events in Korea: multicenter study. J Korean Med Sci. 2012;27:268-73.   DOI
9 Kim NH, Jung HY, Cho SY, Park SU, Park JM, Ko CN. Liver enzyme abnormalities during concurrent use of herbal and conventional medicines in Korea: a retrospective study. Phytomedicine. 2011;18:1208-13.   DOI
10 Jeong TY, Park BK, Cho JH, Kim YI, Ahn YC, Son CG. A prospective study on the safety of herbal medicines, used alone or with conventional medicines. J Ethnopharmacol. 2012;143:884-8.   DOI
11 Mantani N, Kogure T, Sakai S, Goto H, Shibahara N, Kita T, Shimada Y, Terasawa K. Incidence and clinical features of liver injury related to Kampo (Japanese herbal) medicine in 2,496 cases between 1979 and 1999: problems of the lymphocyte transformation test as a diagnostic method. Phytomedicine. 2002;9:280-7.   DOI
12 Amacher DE. Female gender as a susceptibility factor for drug-induced liver injury. Hum Exp Toxicol. 2014;33:928-39.   DOI
13 Kim D, Lee E, Kim H, Ahn IH, Kim SM. The change of renal function in patients with long-term herb medication by frequently prescribed formular. J Korean Orient Med. 1994;15:410-8.
14 Melchart D, Linde K, Hager S, Kaesmayr J, Shaw D, Bauer R, Weidenhammer W. Monitoring of liver enzymes in patients treated with traditional Chinese drugs. Complement Ther Med. 1999;7:208-16.   DOI
15 Pazhayattil GS, Shirali AC. Drug-induced impairment of renal function. Int J Nephrol Renovasc Dis. 2014;7:457-68.   DOI
16 Jang S, Kim KH, Sun SH, Sun SH, Go SH, Go HY, Lee EK, Jang BH, Shin YC, Ko SG. Characteristics of herbal medicine users and adverse events experienced in South Korea: a survey study. Evid Based Complement Alternat Med. 2017;4089019.
17 Cheon C, Kim J, Cho Y, Choi D, Yoon S, Cha J, Jang B, Shin YC, Ko SG. The analysis on the use experience of other medical institution for the same symptoms and the frequent diseases of outpatients of Korean medical institution: based on the 2017 Korean Medicine Utilization and Herbal Medicine Consumption Survey. J Soc Prev Korean Med. 2019;23:13-20.
18 Huerta C, Castellsague J, Varas-Lorenzo C, Garcia Rodriguez LA. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis. 2005;45:531-9.   DOI
19 Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci. 2016;17(1):14.   DOI
20 Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;113:S1-130.
21 Yun YJ, Shin BC, Lee MS, Cho SI, Shin WJ, Park HJ, Lee HJ. Korean herbal medicine on liver function: a systematic review in Korean literature. J Int Korean Med. 2009;30:153-72.
22 Oh SJ, Cho JH, Son CG. Systematic review of the incidence of herbal drug-induced liver injury in Korea. J Ethnopharmacol. 2015;159:253-6.   DOI
23 Lee J, Shin JS, Lee YJ, Kim M, Shin BC, Lee JH, Lee MS, Ha IH. Battle over herb-induced liver injury: low prevalence confirmed through secondary evaluation and research team's clarifying rebuttal to unwarranted public claims. J Altern Complement Med. 2019;25:260-4.   DOI